The University of Chicago Header Logo

Search Results (19)

More Search Options
MatchTypeWhy
Becker, MichaelPerson Why?
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.Academic Article Why?
CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.Academic Article Why?
Febuxostat compared with allopurinol in patients with hyperuricemia and gout.Academic Article Why?
Long-term safety of pegloticase in chronic gout refractory to conventional treatment.Academic Article Why?
Management of Gout.Academic Article Why?
An open-label, 6-month study of allopurinol safety in gout: The LASSO study.Academic Article Why?
Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims.Academic Article Why?
Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy.Academic Article Why?
Diabetes and gout: efficacy and safety of febuxostat and allopurinol.Academic Article Why?
Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study.Academic Article Why?
Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal Impairment.Academic Article Why?
Patient-reported outcomes in chronic gout: a report from OMERACT 10.Academic Article Why?
Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities.Academic Article Why?
What do I need to know about gout?Academic Article Why?
Per Page    Page  of 2last Nextnext
Prev
Search Criteria
  • Gout
Filter by Type
_
Click "Why?" to see why an item matched the search.